Abstract
Human cytomegalovirus (HCMV) genomic polymorphisms have been used to investigate correlations between virus variants and clinical characteristics. We explored the distribution of HCMV glycoprotein N (gN) genotypes and their roles relative to clinical features in a population of Chinese hematopoietic stem cell transplant (HSCT) recipients. This prospective analysis involved HCMV clinical isolates obtained from 102 HSCT patients. Real-time quantitative PCR and PCR-based restriction fragment length polymorphism analysis were applied for the determination of viral loads and gN genotypes. The distribution of HCMV gN genotypes was as follows: gN1, 6/102 (5.9%); gN2, 10/102 (9.8%); gN3a, 17/102 (16.7%); gN3b, 5/102 (4.9%); gN4a, 12/102 (11.7%); gN4b, 9/102 (8.8%); gN4d, 2/102 (2.0%); and mixtures, 41/102 (40.2%). No particular HCMV gN genotype was significantly associated with specific clinical characteristics. The HCMV gN3a genotype was the most prevalent among Chinese HSCT recipients, but HCMV gN genotypes may have no correlation with clinical features in HSCT patients.
Similar content being viewed by others
References
Eckle T, Prix L, Jahn G, Klingebiel T, Handgretinger R, Selle B, Hamprecht K (2000) Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes. Blood 96(9):3286–3289
Hamprecht K, Eckle T, Prix L, Faul C, Einsele H, Jahn G (2003) Ganciclovir-resistant cytomegalovirus disease after allogeneic stem cell transplantation: Pitfalls of phenotypic diagnosis by in vitro selection of an ul97 mutant strain. J Infect Dis 187(1):139–143. doi:10.1086/346240
Eckle T, Lang P, Prix L, Jahn G, Klingebiel T, Handgretinger R, Selle B, Niethammer D, Hamprecht K (2002) Rapid development of ganciclovir-resistant cytomegalovirus infection in children after allogeneic stem cell transplantation in the early phase of immune cell recovery. Bone Marrow Transplant 30(7):433–439. doi:10.1038/sj.bmt.1703666
Marfori JE, Exner MM, Marousek GI, Chou S, Drew WL (2007) Development of new cytomegalovirus ul97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients. J Clin Virol 38(2):120–125. doi:10.1016/j.jcv.2006.11.005
Chou S, Dennison K (1991) Analysis of interstrain variation in cytomegalovirus glycoprotein b sequences encoding neutralization-related epitopes. J Infect Dis 163(6):1229–1234
Pignatelli S, Dal Monte P, Landini M (2001) Gpul73 (gn) genomic variants of human cytomegalovirus isolates are clustered into four distinct genotypes. J Gen Virol 82(Pt 11):2777–2784
Pignatelli S, Dal Monte P, Rossini G, Chou S, Gojobori T, Hanada K, Guo J, Rawlinson W, Britt W, Mach M, Landini M (2003) Human cytomegalovirus glycoprotein n (gpul73-gn) genomic variants: Identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J Gen Virol 84(Pt 3):647–655
Paterson D, Dyer A, Milne R, Sevilla-Reyes E, Gompels U (2002) A role for human cytomegalovirus glycoprotein o (go) in cell fusion and a new hypervariable locus. Virology 293(2):281–294. doi:10.1006/viro.2001.1274
Chou S (1992) Molecular epidemiology of envelope glycoprotein h of human cytomegalovirus. J Infect Dis 166(3):604–607
Rasmussen L, Geissler A, Cowan C, Chase A, Winters M (2002) The genes encoding the gcIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates. J Virol 76(21):10841–10848
Isaacson M, Compton T (2009) Human cytomegalovirus glycoprotein b is required for virus entry and cell-to-cell spread but not for virion attachment, assembly, or egress. J Virol 83(8):3891–3903. doi:10.1128/JVI.01251-08
Britt W, Vugler L, Stephens E (1988) Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55–116 (gb). J Virol 62(9):3309–3318
Navarro D, Paz P, Tugizov S, Topp K, La Vail J, Pereira L (1993) Glycoprotein b of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 197(1):143–158. doi:10.1006/viro.1993.1575
Shepp D, Match M, Lipson S, Pergolizzi R (1998) A fifth human cytomegalovirus glycoprotein b genotype. Res Virol 149(2):109–114. doi:S0923251698800861
Trincado D, Scott G, White P, Hunt C, Rasmussen L, Rawlinson W (2000) Human cytomegalovirus strains associated with congenital and perinatal infections. J Med Virol 61(4):481–487. doi:10.1002/1096-9071
Kari B, Gehrz R (1993) Structure, composition and heparin binding properties of a human cytomegalovirus glycoprotein complex designated gc-II. J Gen Virol 74(Pt 2):255–264
Mach M, Kropff B, Dal Monte P, Britt W (2000) Complex formation by human cytomegalovirus glycoproteins m (gpul100) and n (gpul73). J Virol 74(24):11881–11892
Dal Monte P, Pignatelli S, Mach M, Landini MP (2001) The product of human cytomegalovirus UL73 is a new polymorphic structural glycoprotein (gpUL73). J Hum Virol 4(1):26–34
Bates M, Monze M, Bima H, Kapambwe M, Kasolo FC, Gompels UA (2008) High human cytomegalovirus loads and diverse linked variable genotypes in both HIV-1 infected and exposed, but uninfected, children in Africa. Virology 382(1):28–36. doi:10.1016/j.virol.2008.09.001
Manuel O, Pang XL, Humar A, Kumar D, Doucette K, Preiksaitis JK (2009) An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants. J Infect Dis 199(11):1621–1628. doi:10.1086/598952
Urban M, Britt W, Mach M (1992) The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific. J Virol 66(3):1303–1311
Mattick C, Dewin D, Polley S, Sevilla-Reyes E, Pignatelli S, Rawlinson W, Wilkinson G, Dal Monte P, Gompels UA (2004) Linkage of human cytomegalovirus glycoprotein go variant groups identified from worldwide clinical isolates with gN genotypes, implications for disease associations and evidence for N-terminal sites of positive selection. Virology 318(2):582–597. doi:10.1016/j.virol.2003.09.036
Yan H, Koyano S, Inami Y, Yamamoto Y, Suzutani T, Mizuguchi M, Ushijima H, Kurane I, Inoue N (2008) Genetic linkage among human cytomegalovirus glycoprotein N (gN) and go genes, with evidence for recombination from congenitally and post-natally infected Japanese infants. J Gen Virol 89(Pt 9):2275–2279. doi:10.1099/vir.0.83685-0
Woo P, Lo C, Lo S, Siau H, Peiris J, Wong S, Luk W, Chan T, Lim W, Yuen K (1997) Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease. Clin Diagn Lab Immunol 4(5):515–518
Torok-Storb B, Boeckh M, Hoy C, Leisenring W, Myerson D, Gooley T (1997) Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation. Blood 90(5):2097–2102
Wu X, Wang Y, Xu Y, Wu D, Sun A, Zhu Z, Han Y, Qiu H, Tang X, Fu Z, He G, Li C, Ma X, Liu Y (2010) Cytomegalovirus glycoprotein b genotype in hematopoietic stem cell transplant patients from china. Biol Blood Marrow Transplant 16(5):647–652. doi:10.1016/j.bbmt.2009.12.001
Pignatelli S, Dal Monte P, Rossini G, Camozzi D, Toscano V, Conte R, Landini M (2006) Latency-associated human cytomegalovirus glycoprotein N genotypes in monocytes from healthy blood donors. Transfusion 46(10):1754–1762. doi:10.1111/j.1537-2995.2006.00963.x
Pignatelli S, Dal Monte P, Rossini G, Lazzarotto T, Gatto M, Landini M (2003) Intrauterine cytomegalovirus infection and glycoprotein N (gN) genotypes. J Clin Virol 28(1):38–43. doi:S1386653202002366
Novak Z, Ross SA, Patro RK, Pati SK, Kumbla RA, Brice S, Boppana SB (2008) Cytomegalovirus strain diversity in seropositive women. J Clin Microbiol 46(3):882–886. doi:10.1128/JCM.01079-07
Chen HP, Lin JC, Yang SP, Lan YC, Weng WS, Tsai CH, Ho DM, Liu CY, Cho WL, Chan YJ (2008) The type-2 variant of human cytomegalovirus glycoprotein N (gN-2) is not the rarest in the chinese population of taiwan: Influence of primer design. J Virol Methods 151(1):161–164. doi:10.1016/j.jviromet.2008.03.018
Pignatelli S, Dal Monte P (2009) Epidemiology of human cytomegalovirus strains through comparison of methodological approaches to explore gN variants. New Microbiol 32(1):1–10
Pignatelli S, Lazzarotto T, Gatto MR, Dal Monte P, Landini MP, Faldella G, Lanari M (2010) Cytomegalovirus gN genotypes distribution among congenitally infected newborns and their relationship with symptoms at birth and sequelae. Clin Infect Dis 51(1):33–41. doi:10.1086/653423
Puchhammer-Stockl E, Gorzer I, Zoufaly A, Jaksch P, Bauer CC, Klepetko W, Popow-Kraupp T (2006) Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients. Transplantation 81(2):187–194. doi:10.1097/01.tp.0000194858.50812
Rossini G, Pignatelli S, Dal Monte P, Camozzi D, Lazzarotto T, Gabrielli L, Gatto MR, Landini MP (2005) Monitoring for human cytomegalovirus infection in solid organ transplant recipients through antigenemia and glycoprotein N (gN) variants: evidence of correlation and potential prognostic value of gN genotypes. Microbes Infect 7(5–6):890–896. doi:10.1016/j.micinf.2005.01.016
Pignatelli S, Rossini G, Dal Monte P, Gatto MR, Landini MP (2003) Human cytomegalovirus glycoprotein n genotypes in aids patients. AIDS 17(5):761–763. doi:10.1097/01.aids
Acknowledgments
We thank Xiao-tao Zhao, Yan-rong Zhang and Yuan-yuan Sun for helping us to collect plasma samples.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xia, Cs., Zhang, Z. Analysis of human cytomegalovirus glycoprotein N genotypes in Chinese hematopoietic stem cell transplant recipients. Arch Virol 156, 17–23 (2011). https://doi.org/10.1007/s00705-010-0811-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-010-0811-0